tiprankstipranks
Trending News
More News >
Astellas Pharma (JP:4503)
:4503
Japanese Market
Advertisement

Astellas Pharma (4503) Ratios

Compare
3 Followers

Astellas Pharma Ratios

JP:4503's free cash flow for Q1 2026 was ¥0.81. For the 2026 fiscal year, JP:4503's free cash flow was decreased by ¥ and operating cash flow was ¥0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.17 0.93 0.93 1.45 1.34
Quick Ratio
0.89 0.74 0.74 1.21 1.12
Cash Ratio
0.19 0.26 0.26 0.52 0.46
Solvency Ratio
0.15 0.09 0.09 0.22 0.23
Operating Cash Flow Ratio
0.22 0.13 0.13 0.45 0.37
Short-Term Operating Cash Flow Coverage
0.73 0.37 0.37 4.37 0.00
Net Current Asset Value
¥ -560.71B¥ -778.88B¥ -778.88B¥ 101.39B¥ 51.27B
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.28 0.28 0.08 0.09
Debt-to-Equity Ratio
0.60 0.63 0.63 0.13 0.15
Debt-to-Capital Ratio
0.38 0.39 0.39 0.12 0.13
Long-Term Debt-to-Capital Ratio
0.27 0.22 0.22 0.03 0.00
Financial Leverage Ratio
2.25 2.24 2.24 1.63 1.60
Debt Service Coverage Ratio
1.41 0.39 0.39 2.47 42.08
Interest Coverage Ratio
15.57 13.30 13.30 15.15 31.46
Debt to Market Cap
0.31 0.31 0.31 0.04 0.00
Interest Debt Per Share
506.06 566.05 566.05 114.72 117.69
Net Debt to EBITDA
1.39 3.43 3.43 -0.74 -0.43
Profitability Margins
Gross Profit Margin
78.42%81.76%81.76%81.01%80.48%
EBIT Margin
14.76%2.31%2.31%9.29%12.49%
EBITDA Margin
24.87%12.18%12.18%15.83%18.60%
Operating Profit Margin
15.27%7.77%7.77%8.76%12.01%
Pretax Profit Margin
3.64%1.56%1.56%8.72%12.10%
Net Profit Margin
4.19%1.06%1.06%6.50%9.57%
Continuous Operations Profit Margin
4.18%1.06%1.06%6.42%9.54%
Net Income Per EBT
115.21%68.26%68.26%74.58%79.09%
EBT Per EBIT
23.84%20.04%20.04%99.50%100.77%
Return on Assets (ROA)
2.45%0.48%0.48%4.02%5.32%
Return on Equity (ROE)
5.42%1.07%1.07%6.55%8.50%
Return on Capital Employed (ROCE)
13.33%5.46%5.46%7.69%9.46%
Return on Invested Capital (ROIC)
13.31%3.09%3.09%5.50%7.49%
Return on Tangible Assets
4.30%1.00%1.00%6.31%8.83%
Earnings Yield
2.80%0.58%0.58%2.88%3.51%
Efficiency Ratios
Receivables Turnover
2.91 2.93 2.93 3.55 3.39
Payables Turnover
2.53 1.58 1.58 2.06 1.94
Inventory Turnover
1.37 1.18 1.18 1.65 1.65
Fixed Asset Turnover
6.01 5.46 5.46 5.30 4.82
Asset Turnover
0.58 0.45 0.45 0.62 0.56
Working Capital Turnover Ratio
11.96 13.77 13.77 5.42 5.02
Cash Conversion Cycle
247.10 204.03 204.03 146.09 139.92
Days of Sales Outstanding
125.52 124.73 124.73 102.86 107.70
Days of Inventory Outstanding
265.85 310.41 310.41 220.74 220.83
Days of Payables Outstanding
144.27 231.11 231.11 177.51 188.61
Operating Cycle
391.37 435.14 435.14 323.60 328.53
Cash Flow Ratios
Operating Cash Flow Per Share
134.23 96.18 96.18 180.09 139.18
Free Cash Flow Per Share
114.29 50.18 50.18 131.44 97.85
CapEx Per Share
19.95 46.00 46.00 48.65 41.33
Free Cash Flow to Operating Cash Flow
0.85 0.52 0.52 0.73 0.70
Dividend Paid and CapEx Coverage Ratio
1.43 0.87 0.87 1.74 1.59
Capital Expenditure Coverage Ratio
6.73 2.09 2.09 3.70 3.37
Operating Cash Flow Coverage Ratio
0.27 0.17 0.17 1.64 1.21
Operating Cash Flow to Sales Ratio
0.12 0.11 0.11 0.22 0.20
Free Cash Flow Yield
7.06%3.06%3.06%6.98%5.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.76 172.65 172.65 34.72 28.49
Price-to-Sales (P/S) Ratio
1.50 1.84 1.84 2.26 2.73
Price-to-Book (P/B) Ratio
1.97 1.84 1.84 2.27 2.42
Price-to-Free Cash Flow (P/FCF) Ratio
14.17 32.71 32.71 14.33 19.53
Price-to-Operating Cash Flow Ratio
12.10 17.06 17.06 10.46 13.73
Price-to-Earnings Growth (PEG) Ratio
0.59 -2.09 -2.09 -1.81 8.60
Price-to-Fair Value
1.97 1.84 1.84 2.27 2.42
Enterprise Value Multiple
7.41 18.49 18.49 13.52 14.24
Enterprise Value
3.58T 3.61T 3.61T 3.25T 3.43T
EV to EBITDA
7.41 18.49 18.49 13.52 14.24
EV to Sales
1.84 2.25 2.25 2.14 2.65
EV to Free Cash Flow
17.46 40.15 40.15 13.59 18.96
EV to Operating Cash Flow
14.86 20.95 20.95 9.92 13.33
Tangible Book Value Per Share
23.73 -154.20 -154.20 339.03 288.61
Shareholders’ Equity Per Share
825.34 889.98 889.98 828.54 789.48
Tax and Other Ratios
Effective Tax Rate
-0.15 0.32 0.32 0.25 0.21
Revenue Per Share
1.08K 894.27 894.27 834.40 700.74
Net Income Per Share
45.43 9.50 9.50 54.24 67.08
Tax Burden
1.15 0.68 0.68 0.75 0.79
Interest Burden
0.25 0.68 0.68 0.94 0.97
Research & Development to Revenue
0.16 0.18 0.18 0.18 0.19
SG&A to Revenue
0.00 0.46 0.46 0.42 0.42
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.95 10.12 10.12 2.48 1.64
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis